Results 291 to 300 of about 1,176,884 (363)

The transcriptional profile of iron deficiency in patients with heart failure: Heme‐sparing and reduced immune processes

European Journal of Heart Failure, EarlyView.
The analysis workflow, findings and potential clinical consequences of iron deficiency in heart failure (HF). From 881 patients with worsening HF, whole blood transcriptome was analysed using the Affymetrix Human Transcriptome Array (HTA) 2.0. Subjects were stratified according to their transferrin saturation (TSAT) levels as iron‐deficient (TSAT <20%)
Niels Grote Beverborg, Ridha I.S. Alnuwaysir, George Markousis‐Mavrogenis, Martijn F. Hoes, Haye H. van der Wal, Simon P.R. Romaine, Mintu Nath, Andrea Koekoemoer, John G.F. Cleland, Chim C. Lang, Stefan D. Anker, Kenneth Dickstein, Marco Metra, Leong L. Ng, Dirk J. van Veldhuisen, Adriaan A. Voors, Nilesh J. Samani, Peter van der Meer   +17 more
wiley   +1 more source

Recent advances of trace elements in autoimmune thyroid disease. [PDF]

Front Immunol
Li S, Xu Q, Wang S, Peng H, Liu Y.
europepmc   +1 more source

Comorbidity trajectories before and after the diagnosis of heart failure: A UK Biobank cohort study

European Journal of Heart Failure, EarlyView.
Time of diagnosis of comorbidities in relation to heart failure. COPD, chronic obstructive pulmonary disease; MI, myocardial infarction. Abstract Aims Heart failure (HF) is frequently associated with multiple comorbidities. We aimed to define their trajectory of accrual to identify opportunities for disease prevention. Methods and results We identified
Hugo MacGowan, Oliver I. Brown, Michael Drozd, Andrew M.N. Walker, Marilena Giannoudi, Sam Straw, Maria F. Paton, John Gierula, Melanie McGinlay, Kathryn J. Griffin, Klaus K. Witte, Mark T. Kearney, Richard M. Cubbon   +12 more
wiley   +1 more source

Clinical Implications and Application of Molecular Testing in the Diagnosis and Management of Thyroid Nodules in the Chinese Population. [PDF]

Clin Cancer Res
Ding M, Wu G, Zhang S, Xie R, Yuan J, Xiao G, Zhang X, Dai J, Chen J, Wang S, Zhou R, Li X, Zhao J, Ning F, Wu Z, Yin Z, Fei J.   +16 more
europepmc   +1 more source

Stable Iodine Intake and Thyroid Screening Outcomes After the Fukushima Nuclear Disaster: An Observational Study.

J Clin Endocrinol Metab
Nishikawa Y, Oguro F, Suzuki C, Kobashi Y, Ito N, Takahashi Y, Nakayama T, Goto A, Tsubokura M.   +8 more
europepmc   +1 more source

Reassessing sonography-based malignancy prediction in categories III and IV of previous Bethesda System for Reporting Thyroid Cytopathology in thyroidology. [PDF]

Rev Assoc Med Bras (1992)
Sengul I, Sengul D.
europepmc   +1 more source

ABO blood group and Rhesus factor as potential markers in papillary thyroid cancer: a retrospective comparative analysis (2015-2023). [PDF]

Langenbecks Arch Surg
Aydoğdu YF, Büyükkasap Ç, Göbüt H, Akın M.   +3 more
europepmc   +1 more source

Methionyl-tRNA synthetase 1 expression, the possibility as a diagnostic and prognostic factor in papillary thyroid cancer. [PDF]

BMC Cancer
Park S, Lee JS, Jeong HJ, Yun HJ, Kim SM, Nahm JH, Chang H, Lee YS, Chang HS.   +8 more
europepmc   +1 more source

Thyroid function and cognitive health: rethinking the relationship between "suboptimal" TSH/FT4 levels and cognitive decline. [PDF]

Alzheimers Dement
Dori D, Seixas-Lima B, Roncero C, Lahiri D, Borrie M, Chertkow H.   +5 more
europepmc   +1 more source

Impact of thyroid dysfunction and diabetes on fibrosis and steatosis stages in metabolic dysfunction associated fatty liver disease. [PDF]

Sci Rep
Saleh MW, Farghly MI, Elsebaie E, Mohamed N, El-Mankhly E.   +4 more
europepmc   +1 more source